Position in PTCT
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$15,469,528
+$14,548,286 QoQ
Shares Held
227,059
+1772.2% QoQ
Ownership
2.74%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HSBC HOLDINGS PLC holds $964,220,373 across 121 Biotechnology names. PTCT ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
655,443 | $292,681,510 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
323,338 | $249,823,869 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,544,018 | $74,066,541 | |
| 4 | INCY |
Incyte Corp
|
582,368 | $54,812,474 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
89,619 | $29,652,235 | |
| 6 | MRNA |
Moderna, Inc.
|
490,088 | $24,896,468 | |
| 7 | INSM |
INSMED Inc
|
116,456 | $19,042,883 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
This page
|
227,059 | $15,469,528 |
All Filings in PTCT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,469,528 | 227,059 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $921,242 | 12,128 | Shares | Sole | 2026-03-20 | |
| 2025-09-30 | $10,954,482 | 178,499 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,465,688 | 30,010 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $902,552 | 17,711 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $743,365 | 16,468 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $777,875 | 20,967 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $578,512 | 18,918 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $674,858 | 23,199 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $476,402 | 17,286 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $680,187 | 30,352 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,588,853 | 39,067 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $669,730 | 13,826 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,739,253 | 45,566 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $791,051 | 15,758 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $967,327 | 24,147 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,309,076 | 61,889 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,818,528 | 70,764 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,577,683 | 69,274 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,155,365 | 27,333 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $853,860 | 18,033 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $431,482 | 7,070 | Shares | Defined | 2021-02-25 | |
| 2020-09-30 | $1,141,915 | 24,426 | Shares | Defined | 2020-11-12 | |
| 2020-03-31 | $223,005 | 4,999 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||